TASSO, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 3.170
Totale 3.170
Nazione #
IT - Italia 3.170
Totale 3.170
Città #
Genova 2.376
Rapallo 394
Genoa 391
Bordighera 9
Totale 3.170
Nome #
Bone Turnover in Wild Type and Pleiotrophin-Transgenic Mice Housed for Three Months in the International Space Station (ISS). 136
Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone 132
Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic 127
The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model 123
Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway 119
Circulating healing (CH) cells expressing BST2 are functionally activated by the injury-regulated systemic factor HGFA 118
An Alu-like RNA promotes cell differentiation and reduces malignancy of human neuroblastoma cells. 117
In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche. 115
Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: Endorsement of macrophage polarization 115
Harnessing Endogenous Cellular Mechanisms for Bone Repair 115
Down-regulation of 21A Alu RNA as a tool to boost proliferation maintaining the tissue regeneration potential of progenitor cells 112
The Regenerative Role of the Fetal and Adult Stem Cell Secretome 110
Isolation and Flow Cytometry Characterization of Extracellular-Vesicle Subpopulations Derived from Human Mesenchymal Stromal Cells 108
Development of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds 106
Delivery of cellular factors to regulate bone healing 106
Learning from Mother Nature: Innovative Tools to Boost Endogenous Repair of Critical or Difficult-to-Heal Large Tissue Defects 105
Organization of extracellular matrix fibers within polyglycolic acid-polylactic acid scaffolds analyzed using X-ray synchrotron-radiation phase-contrast micro computed tomography 101
Identification of a New Cell Population Constitutively Circulating in Healthy Conditions and Endowed with a Homing Ability Toward Injured Sites 100
A Method for Isolating and Characterizing Mesenchymal Stromal Cell-derived Extracellular Vesicles 96
Dichloroacetate (DCA) Inhibits Neuroblastoma Growth by Specifically Acting against Malignant Undifferentiated Cells 89
Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. 88
THE DEVELOPMENT OF TISSUE-ENGINEERED BONE OF DIFFERENT ORIGIN THROUGH ENDOCHONDRAL AND INTRAMEMBRANOUS OSSIFICATION FOLLOWING THE IMPLANTATION OF MESENCHYMAL STEM CELLS AND OSTEOBLASTS IN A MURINE MODEL. 84
Mesenchymal Stem Cells induce functionally active T regulatory lymphocytes in a paracrine fashion and ameliorate Experimental Autoimmune Uveitis. 82
When stem cells meet immunoregulation 79
The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. 78
Extracellular Vesicles as Natural, Safe and Efficient Drug Delivery Systems 78
Immunomodulant activity of mesenchymal stem cells is strain-specific and correlates with susceptibility to autoimmunity 68
Mesenchymal stem cells paracrine activity is modulated by platelet lysate: induction of an inflammatory response and secretion of factors maintaining macrophages in a pro-inflammatory phenotype. 63
Dissecting the effects of preconditioning with inflammatory cytokines and hypoxia on the angiogenic potential of mesenchymal stromal cell (MSC)-derived soluble proteins and extracellular vesicles (EVs) 58
The human fetal and adult stem cell secretome can exert cardioprotective paracrine effects against cardiotoxicity and oxidative stress from cancer treatment 44
Role of extracellular vesicles from adipose tissue- and bone marrow-mesenchymal stromal cells in endothelial proliferation and chondrogenesis 42
Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications 39
The regenerative potential of the amniotic fluid stem cells secretome 36
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors 29
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis 28
Editorial: Bone and Cartilage Regeneration With Extracellular Vesicles 27
Preconditioned Mesenchymal Stromal Cell-Derived Extracellular Vesicles (EVs) Counteract Inflammaging 25
Editorial: Extracellular Vesicles in Bone Oncology 22
Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer management 19
Targeting PIK3CA Actionable Mutations in the Circulome: A Proof of Concept in Metastatic Breast Cancer 19
Standardized Method to Functionalize Plasma-Extracellular Vesicles via Copper-Free Click Chemistry for Targeted Drug Delivery Strategies 11
In vivo recruitment of two {"}waves{"} of host{'}s stem/progenitor cells by exogenous mesenchymal stem cells seeded onto porous ceramic scaffolds and role of endothelial progenitors in the new bone formation 7
Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients 6
Totale 3.282
Categoria #
all - tutte 11.102
article - articoli 11.102
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.204


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020951 44 28 37 58 92 116 140 75 95 145 92 29
2020/2021307 18 25 20 29 32 12 29 25 23 42 32 20
2021/2022475 14 15 53 42 24 37 21 109 22 46 29 63
2022/2023463 36 44 6 29 93 52 4 52 84 5 52 6
2023/2024342 14 37 7 46 27 53 28 23 17 12 21 57
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 3.282